Figure 1
Gabapentin Capsule
Product Images NDC 80425-0079
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2
This text appears to be a chart or graph showing a study measuring mean pain scores with two different doses of gabapentin and a placebo. The study had a three-week dose titration period followed by a four-week fixed dose period. The listed time periods are likely weeks or days. The chart shows baseline measurements and six additional measurements (labeled 1-6) taken throughout the study.*
Figure 3
Figure 4
Gabapentin 300mg Cap Qty 30 Ndc 80425 0079
This appears to be a packing slip for a medication called Gabapentin. The contents include 30 capsules of Gabapentin 300 mcg, packed by a company or entity named AAdvanced. The text does not provide any indication of the purpose or use of Gabapentin.*
Gabapentin 300mg Cap Qty 60 Ndc 80425 0079
This text is not readable as it does not provide sufficient information to generate a useful description. Please provide readable text for evaluation.*
Gabapentin 300mg Cap Qty 90 Ndc 80425 0079
Structure
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
